Related Experiment Video
Updated: Jul 20, 2026
04:36
An Assay to Detect Protection of the Retinal Vasculature from Diabetes-Related Death in Mice
Published on: January 12, 2024
[Selective retina therapy in patients with diabetic maculopathy]
H Elsner1, C Klatt, S H M Liew
1Klinik für Augenheilkunde, UKSH, Campus Kiel, Hegewischstrasse 2, 24105 Kiel, Germany. helsner@ophthalmol.uni-kiel.de
Summary
Selective Retina Therapy (SRT) offers a safe new treatment for diabetic maculopathy, stabilizing vision and reducing leakage. This laser therapy is particularly effective for fovea-adjacent pathologies unsuitable for traditional methods.
Area of Science:
- Ophthalmology
- Retinal diseases
- Laser therapy
Background:
- Diabetic maculopathy affects vision, particularly when near the fovea.
- Conventional laser treatments have limitations for fovea-adjacent lesions.
Purpose of the Study:
- To evaluate the safety and efficacy of Selective Retina Therapy (SRT) for diabetic maculopathy.
- To assess SRT's impact on visual acuity, leakage, exudation, and retinal thickness.
Main Methods:
- 39 patients with nonischemic, focal, or focal-diffuse diabetic maculopathy were treated with SRT.
- The study monitored visual acuity, angiographic leakage, lipid exudation, and foveal retinal thickness post-treatment.
Main Results:
- SRT demonstrated stabilizing effects on visual acuity.
- The treatment reduced angiographic leakage and lipid exudation.
- Foveal retinal thickness was also stabilized by SRT.
- SRT proved safe for patients.
Conclusions:
- Selective Retina Therapy is a safe and effective treatment for diabetic maculopathy.
- SRT is particularly beneficial for pathologies located near the fovea.
- SRT offers an alternative to conventional laser photocoagulation for specific cases.
